Krensavage Asset Management

Krensavage Asset Management: an SEC-registered investment advisor with no publicly disclosed strategy, team, or holdings. Profile based on public record.

Krensavage Asset Management

KRENSAVAGE ASSET MANAGEMENT, LLC launched in 2008 to pursue a concentrated value-oriented approach to healthcare investing. KAM primarily focuses on pharmaceutical, medical device, and commercial-biotechnology companies and aims to take advantage of market inefficiencies by investing both long and short.

linkedin.com/company/krensavage-asset-management-llc

General information

Firm type

RIA

Year founded

—

AUM

Undisclosed

Location

Region

—

Country

—

City

—

Corporate office

—

What is known about Krensavage Asset Management's investment strategy?

Public records do not disclose Krensavage's specific investment strategy. As an SEC-registered advisor, it likely manages a diversified portfolio, but no details on asset-class preference, sector focus, or deal structure are available.

Who are the principals or investment team at Krensavage?

No principals are publicly named. The firm does not maintain a public website or LinkedIn presence that lists team members. SEC filings may contain names of registered individuals, but those are not incorporated in this profile.

Does Krensavage Asset Management invest in private markets or only public securities?

It is unclear. The firm's SEC registration allows for broad investment discretion, but no public information confirms private market activity. Without portfolio disclosures, the asset-class mix is unknown.

Is Krensavage a single-family office or an asset manager?

The firm is registered as an investment advisor (RIA), not a family office. This suggests it manages capital for multiple clients. However, the underlying ownership structure is not public.

Where does Krensavage Asset Management operate?

A headquarters location has not been publicly identified. No additional offices or geographic footprint are recorded in public sources.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: May 30, 2026. Continuous refresh with full update cycles at least every 30 days.